It was revealed last week that 46 Australian patients received tissue implants from Biomedical Tissue Services (BTS), a company under investigation and now shut down by the United States Food and Drug Administration for illegally obtaining body parts from cadavers (many of which were diseased) and placing them in the stream of commerce.
A tragic scandal now has repercussions beyond the New Jersey shores where BTS is located. Patients who received body parts from BTS have filed lawsuits claiming to have contracted syphilis, hepatitis and other diseases from the bones and tissues they received from pillaged cadavers. The emptied corpses were sent to funeral homes in New York to prepare for burial. Yet, Michael Mastromarino, the CEO of BTS, and his colleagues had other macabre business objectives in mind, including looting the corpses for profit.